-
International Journal of Radiation... Apr 2021Osteoradionecrosis is a relatively rare but potentially morbid and costly complication of radiation therapy for head and neck cancer. Multidisciplinary diagnosis and...
Osteoradionecrosis is a relatively rare but potentially morbid and costly complication of radiation therapy for head and neck cancer. Multidisciplinary diagnosis and treatment are essential. Despite evidence guiding individual aspects of care for osteoradionecrosis, there is a lack of broad consensus on the overall diagnosis and management of this condition. This study comprehensively reviews the literature, with a focus on the past 10 years, to guide evaluation and treatment.
Topics: Bone Density Conservation Agents; Consensus; Head and Neck Neoplasms; Humans; Incidence; Mandible; Mandibular Osteotomy; Osteoradionecrosis; Ozone; Proton Therapy; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Risk Factors; Teriparatide; Tooth Extraction; Ultrasonic Therapy
PubMed: 33412258
DOI: 10.1016/j.ijrobp.2020.12.043 -
Oral and Maxillofacial Surgery Clinics... Aug 2011Osteoradionecrosis (ORN) is a severe complication of radiation therapy for head and neck cancer. The current theory in its pathophysiology is thought to be... (Review)
Review
Osteoradionecrosis (ORN) is a severe complication of radiation therapy for head and neck cancer. The current theory in its pathophysiology is thought to be radiation-induced fibroatrophy of the bone. Location of primary tumor, stage of cancer, dose of radiation, oral hygiene, and smoking and alcohol use are risk factors in the development of ORN. Prevention is focused on thorough dental care before, during, and after radiation therapy. Treatment ranges from conservative management with oral rinses and local debridement to radical resection with microvascular free tissue transfer and reconstruction.
Topics: Alcohol Drinking; Dental Care; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Mandible; Mandibular Diseases; Neoplasm Staging; Oral Hygiene; Osteoradionecrosis; Radiotherapy Dosage; Risk Factors; Smoking
PubMed: 21798443
DOI: 10.1016/j.coms.2011.04.011 -
Journal of Neuro-oncology Dec 2020Radiation therapy (RT) is often necessary for the treatment of head and neck cancers. Osteoradionecrosis (ORN) is a rare, but potentially serious complication of RT. RT... (Review)
Review
Radiation therapy (RT) is often necessary for the treatment of head and neck cancers. Osteoradionecrosis (ORN) is a rare, but potentially serious complication of RT. RT leads to the destruction of vasculature in radiated tissue causing hypoxia and tissue necrosis. ORN can occur in any bone, but bones with naturally poor blood supply appear to be more susceptible. Bones of the skull base are susceptible, with ORN occurring in the anterior, central, and lateral skull base. Risk factors include cancer type and location, radiation dose, and a variety of patient factors. Patients often present with pain, bleeding, and foul odor and are typically found to have exposed and necrotic bone. Treatment options vary depending on the severity, but typically include pentoxifylline and vitamin E as well as surgical debridement, with less evidence supporting hyperbaric oxygen therapy. Recognition and prompt treatment of ORN will allow for improved patient outcomes.
Topics: Animals; Head and Neck Neoplasms; Humans; Osteoradionecrosis; Radiotherapy; Skull Base Neoplasms
PubMed: 32394326
DOI: 10.1007/s11060-020-03462-3 -
International Dental Journal Feb 2018Osteoradionecrosis (ORN) of the jaws is a pernicious complication of radiation therapy for head and neck tumours. This article aims to provide an update on data related... (Review)
Review
Osteoradionecrosis (ORN) of the jaws is a pernicious complication of radiation therapy for head and neck tumours. This article aims to provide an update on data related to the definition, epidemiology, staging, and clinical and radiological findings of ORN of the jaws. Using certain keywords, an electronic search was conducted spanning the period from January 1922 to April 2014 to identify the available related investigations. Pooled data were then analysed. ORN is described as exposed irradiated bone that fails to heal over a period of 3 months without evidence of persisting or recurrent tumour. The prevalence of ORN varies in the literature. Several staging or scoring systems of ORN have been proposed. Clinical findings include ulceration or necrosis of the mucosa with exposure of necrotic bone. Radiological findings are not evident in the early stages of ORN. Furthermore ORN may not be apparent in imaging even when the disease is advanced. Taking into account the severity of ORN and the difficulties in diagnosing it early and accurately, the clinician should be aware of this complex entity in order to prevent its appearance or the development of more severe complications.
Topics: Head and Neck Neoplasms; Humans; Necrosis; Osteoradionecrosis; Prevalence; Radiotherapy; Ulcer
PubMed: 28649774
DOI: 10.1111/idj.12318 -
Current Opinion in Otolaryngology &... Oct 2019To describe current standard of care for osteoradionecrosis (ORN) of the mandible and report possible future trends. (Review)
Review
PURPOSE OF REVIEW
To describe current standard of care for osteoradionecrosis (ORN) of the mandible and report possible future trends.
RECENT FINDINGS
Cutting guides may be used to reduce surgical time and possibly improve outcomes. There has also been recent investigation into the use of pentoxifylline and tocopherol or pentoxifylline, tocopherol and clodronate (a well known conservative medial regime) as a prevention for development of ORN after dental extractions and the first randomized controlled study is upcoming. Augmented reality has shown promise as a comparable and inexpensive possible alternative to cutting guides.
SUMMARY
Current standard of care involves conservative/supportive therapy with antioxidants, antibiotics, steroids, and pain control for low-grade ORN with surgery reserved for high-grade/progressive ORN with refractory to conservative therapy and with significant oral dysfunction.
Topics: Antioxidants; Humans; Mandible; Osteoradionecrosis; Plastic Surgery Procedures; Surgical Flaps
PubMed: 31389851
DOI: 10.1097/MOO.0000000000000571 -
Clinical Oral Investigations Oct 2021This systematic review assesses dental implant survival, calculates the incidence rate of osteoradionecrosis, and evaluates risk factors in irradiated head and neck... (Meta-Analysis)
Meta-Analysis Review
OBJECTIVES
This systematic review assesses dental implant survival, calculates the incidence rate of osteoradionecrosis, and evaluates risk factors in irradiated head and neck cancer patients.
MATERIALS AND METHODS
Various databases (e.g., Medline/Embase using Ovid) and gray literature platforms were searched using a combination of keywords and subject headings. When appropriate, meta-analysis was carried out using a random effects model. Otherwise, pooled analysis was applied.
RESULTS
A total of 425 of the 660 included patients received radiotherapy. In total, 2602 dental implants were placed, and 1637 were placed in irradiated patients. Implant survival after an average follow-up of 37.7 months was 97% (5% confidence interval, CI 95.2%, 95% CI 98.3%) in nonirradiated patients and 91.9% (5% CI 87.7%, 95% CI: 95.3%) after an average follow-up of 39.8 months in irradiated patients. Osteoradionecrosis occurred in 11 cases, leading to an incidence of 3% (5% CI 1.6%, 95% CI 4.9%). The main factors impacting implant survival were radiation and grafting status, while factors influencing osteoradionecrosis could not be determined using meta-analysis.
CONCLUSION
Our data show that implant survival in irradiated patients is lower than in nonirradiated patients, and osteoradionecrosis is-while rare-a serious complication that any OMF surgeon should be prepared for. The key to success could be a standardized patient selection and therapy to improve the standard of care, reduce risks and shorten treatment time.
CLINICAL RELEVANCE
Our analysis provides further evidence that implant placement is a feasible treatment option in irradiated head and neck cancer patients with diminished oral function and good long-term cancer prognosis.
Topics: Dental Implantation, Endosseous; Dental Implants; Head and Neck Neoplasms; Humans; Osteoradionecrosis
PubMed: 34401944
DOI: 10.1007/s00784-021-04065-6 -
Strahlentherapie Und Onkologie : Organ... Mar 2022To seek evidence for osteoradionecrosis (ORN) after dental extractions before or after intensity-modulated radiotherapy (IMRT) for head and neck cancer (HNC). (Meta-Analysis)
Meta-Analysis Review
OBJECTIVE
To seek evidence for osteoradionecrosis (ORN) after dental extractions before or after intensity-modulated radiotherapy (IMRT) for head and neck cancer (HNC).
METHODS
Medline/PubMed, Embase, and Cochrane Library were searched from 2000 until 2020. Articles on HNC patients treated with IMRT and dental extractions were analyzed by two independent reviewers. The risk ratios (RR) and odds ratios (OR) for ORN related to extractions were calculated using Fisher's exact test. A one-sample proportion test was used to assess the proportion of pre- versus post-IMRT extractions. Forest plots were used for the pooled RR and OR using a random-effects model.
RESULTS
Seven of 630 publications with 875 patients were eligible. A total of 437 (49.9%) patients were treated with extractions before and 92 (10.5%) after IMRT. 28 (3.2%) suffered from ORN after IMRT. ORN was associated with extractions in 15 (53.6%) patients, eight related to extractions prior to and seven cases related to extractions after IMRT. The risk and odds for ORN favored pre-IMRT extractions (RR = 0.18, 95% CI: 0.04-0.74, p = 0.031, I = 0%, OR = 0.16, 95% CI: 0.03-0.99, p = 0.049, I = 0%). However, the prediction interval of the expected range of 95% of true effects included 1 for RR and OR.
CONCLUSION
Tooth extraction before IMRT is more common than after IMRT, but dental extractions before compared to extractions after IMRT have not been proven to reduce the incidence of ORN. Extractions of teeth before IMRT have to be balanced with any potential delay in initiating cancer therapy.
Topics: Head and Neck Neoplasms; Humans; Incidence; Osteoradionecrosis; Radiotherapy, Intensity-Modulated; Tooth Extraction
PubMed: 35029717
DOI: 10.1007/s00066-021-01896-w -
Oral Oncology Jun 2010Osteoradionecrosis (ORN) of the mandible is the most serious and severe side effect of combined treatment of head and neck tumors. A new theory for the pathogenesis of... (Review)
Review
Osteoradionecrosis (ORN) of the mandible is the most serious and severe side effect of combined treatment of head and neck tumors. A new theory for the pathogenesis of ORN has been proposed relating it to a fibro-atrophic mechanism including free radical formation, endothelial dysfunction, inflammation, microvascular thrombosis leading to bone and tissue necrosis. Risk factors mainly include radiation related risk factors, surgery and, tobacco and alcohol abuse. Removing of diseased teeth after and even probably after radiotherapy is generally considered the main risk factor in ORN. Conversely, steroid use before or after radiation may have a protective effect related to the inhibition of the initial inflammatory phase of ORN. Prevention of ORN is still based on the preventive extractions of decayed or periodontally compromised teeth before radiotherapy. Based on the current understanding of ORN pathophysiology, new preventive and therapeutic protocols have been suggested for mild to moderate stages. Free tissue surgical transfers is the treatment of choice of severe, extensive and long established ORN.
Topics: Female; Head and Neck Neoplasms; Humans; Male; Mandibular Diseases; Osteoradionecrosis; Plastic Surgery Procedures; Risk Factors
PubMed: 20457536
DOI: 10.1016/j.oraloncology.2010.03.017 -
British Dental Journal Aug 2020
Topics: Humans; Mandibular Diseases; Osteoradionecrosis; Surveys and Questionnaires
PubMed: 32811923
DOI: 10.1038/s41415-020-2020-x -
Current Opinion in Otolaryngology &... Aug 2005Osteoradionecrosis of the mandible is a serious complication of radiation therapy to the head and neck. Given the increased use of radiation therapy and combined... (Review)
Review
PURPOSE OF REVIEW
Osteoradionecrosis of the mandible is a serious complication of radiation therapy to the head and neck. Given the increased use of radiation therapy and combined chemotherapy-radiation therapy regimens in treatment of head and neck malignancies, it is anticipated that osteoradionecrosis will continue to be an important clinical problem. Recently, new concepts have been introduced regarding the pathogenesis of osteoradionecrosis, and these ideas help outline new guidelines for treatment.
RECENT FINDINGS
Current literature focuses on the probability of a fibroatrophic mechanism for the development of osteoradionecrosis, rather than the traditional vascular insufficiency mechanism. Because of the evolution of this new idea, as well as a double-blinded, placebo-controlled study finding no benefit from the use of hyperbaric oxygen for advanced osteoradionecrosis of the mandible, new treatment considerations have emerged. Ongoing research is also being conducted to clarify the role of osteoclasts in the pathogenesis of osteoradionecrosis. Restoration of blood supply or vascularized tissue to the affected area continues to be of primary importance in the resolution of osteoradionecrosis.
SUMMARY
It is clear that the cause and pathogenesis of osteoradionecrosis are far more complex than originally believed. Current and future research on this multifaceted topic will focus on the cellular basis of this condition, because as it is elucidated, more effective medical treatment regimens will become evident.
Topics: Disease Progression; Head and Neck Neoplasms; Humans; Incidence; Mandible; Mandibular Diseases; Osteoradionecrosis; Radiotherapy, Adjuvant; Risk Factors
PubMed: 16012245
DOI: 10.1097/01.moo.0000170527.59017.ff